<link rel="stylesheet" href="styles.f3b1fba60ec7970c.css">

Evaluation of adiponectin and lipoprotein(a) levels in cardiac syndrome x

dc.authorid0000-0002-4607-5724
dc.authorid0000-0003-1919-3183
dc.authorid0000-0001-9975-5507
dc.authorid0000-0001-5825-8627
dc.authorid0000-0002-4281-0867
dc.contributor.authorGüler, Ekrem
dc.contributor.authorGüler, Gamze
dc.contributor.authorKızılırmak, Filiz
dc.contributor.authorBatgerel, Ulaankhuu
dc.contributor.authorDemir, Gültekin Günhan
dc.contributor.authorGüneş, Hacı Murat
dc.contributor.authorKaraca, Oğuz
dc.contributor.authorÖzcan, Özgür
dc.contributor.authorBarutçu, İrfan
dc.contributor.authorTürkmen, Muhsin
dc.contributor.authorEsen, Ali Metin
dc.date.accessioned10.07.201910:49:13
dc.date.accessioned2019-07-10T19:56:12Z
dc.date.available10.07.201910:49:13
dc.date.available2019-07-10T19:56:12Z
dc.date.issued2015
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Kardiyoloji Ana Bilim Dalı
dc.descriptionWOS: 000362565500013
dc.descriptionPubMed ID: 25676008
dc.description.abstractAims. Low adiponectin and high lipoprotein(a) [Lp(a)] levels are associated with endothelial dysfunction, atherosclerosis, and coronary artery disease. Cardiac syndrome X (CSX) is characterized by anginal symptoms, positive stress test, and documentation of normal epicardial coronary arteries with angiography. In this study we aimed to investigate the relationship between CSX and circulating levels of adiponectin and Lp(a). Patients and methods. We enrolled 53 female patients with CSX and 33 patients as the control group. The diagnosis of CSX was made according to presence of angina, findings suggestive of ischemia during stress electrocardiography or myocardial perfusion scintigraphy, and documentation of normal coronary arteries in coronary angiography. The control group consisted of patients with atypical angina and normal stress electrocardiography test results. Both groups were matched in terms of hypertension, diabetes mellitus, and metabolic syndrome. Results. Adiponectin levels were significantly decreased in patients with CSX (4.57 mu g/ml vs. 13.18 mu g/ml; p=0.001); however, Lp(a) levels were significantly increased (36.30 mg/dl vs. 7.24 mg/dl; p<0.001). Low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and triglycerides (TG) concentrations did not differ between the case group and the control group (p=0.14, p=0.62, p=0.64, respectively). There was no significant difference between groups in terms of age, body mass index, waist circumference hypertension, hyperlipidemia, diabetes mellitus, or metabolic syndrome. In multivariate analysis, Lp(a) and adiponectin were found to be independent predictors of CSX. An Lp(a) level of >21 mg/dl had 84% sensitivity and 96% specificity {area under the curve (AUC)=0.922, p<0.0001, 95% CI [0.842-0.970]} and an adiponectin level of <= 5.18 mu g/ml also had 58.7% sensitivity and 82.1% specificity (AUC=0.726, p=0.0003, 95% CI [ 0.609-0.823]) for detecting CSX. Conclusion. We detected low adiponectin and high Lp(a) levels in patients with CSX and these findings may be related to the microvascular injury in CSX.
dc.identifier.citationGüler, E., Güler, G., Kızılırmak, F., Batgerel, U., Demir, G. G., Güneş, H. M. ... Esen, A. M. (2015). Evaluation of adiponectin and lipoprotein(a) levels in cardiac syndrome x. Herz, 40(3), 291-297. https://dx.doi.org/10.1007/s00059-014-4191-1
dc.identifier.doi10.1007/s00059-014-4191-1
dc.identifier.endpage297
dc.identifier.issn0340-9937
dc.identifier.issn1615-6692
dc.identifier.issue3
dc.identifier.scopusqualityQ3
dc.identifier.startpage291
dc.identifier.urihttps://dx.doi.org/10.1007/s00059-014-4191-1
dc.identifier.urihttps://hdl.handle.net/20.500.12511/2616
dc.identifier.volume40
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherUrban & Vogel
dc.relation.ispartofHerzen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/embargoedAccess
dc.subjectAdiponectin
dc.subjectLipoprotein(a)
dc.subjectCardiac Syndrome X
dc.subjectMicrovascular Injury
dc.subjectEtiopathogenesis
dc.titleEvaluation of adiponectin and lipoprotein(a) levels in cardiac syndrome x
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
guler, ekrem-2015.pdf
Size:
434.15 KB
Format:
Adobe Portable Document Format
Description:
Tam Metin / Full Text